{
    "nctId": "NCT03495609",
    "officialTitle": "The Use of Recombinant hCG to Prevent Breast Cancer in BRCA1 and BRCA2 Carriers",
    "genderBased": true,
    "genderDescription": "Only females who are BRCA1 or BRCA2 carriers and who are premenopausal will be included",
    "inclusionCriteria": "* premenopausal women\n* BRCA1 carrier\n* Must be FEMALE\n* Must have minimum age of 18 Years\n* Must have maximum age of 30 Years",
    "exclusionCriteria": "* History of allergic reaction to compounds of similar chemical or biologic composition to hCG\n* receiving medication that could interfere with the study protocol objectives (hormonal contraceptives, androgens, prednisone, thyroid hormones, insulin)\n* previous treatment with follicle stimulating hormone for assisted reproduction\n* uncontrolled intercurrent illness\n* Heart disease\n* Severe cognitive decline\n* Psychiatric desease\n* HIV positive\n* Hepatitis B or C infection"
}